Scancell founder says the company is ready to commercialise novel medicines to counteract cancer. Watch the video here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
who was ramping at that time ?....8p is a thousand miles away now
I bought at 8p. losing a bit so hope it turns good
Or he lol
She is trying to find another means to ramp
where are you ?
No problem buying today. How much would you like to buy. Make sure on fri you say the same ramp again
It's very difficult to buy any significant volume here. Maybe £2k maximum sometimes. But then the price is often higher than for £1k worth. Looks like something is brewing. The idiot who sold at 1.2p odd yeaterday lol probably Investor1111
The Directors interview and recent high of 8p is good enough to answer your question. However try in small chunks, £1k worth at a time or so.
I got in touch with broker to double my holding in OKYO,that was at 4/15 pm this afternoon.They quoted 3.2 to buy,so no way paying that price,I wanted 175,000, that was the reason for the hike,wanting such a large amount,but surely that's is chicken feed!
...All you need is:
listen to this interview with Director, he is also the CEO of TILS (worth £133 millions in AIM and getting listed in NASDAQ soon. Go to this link: http://okyopharma.com
Our Largest share holder Panitta Partners (47% holder) also a major holder in TILS, Okyo Share price went as high as 8p few weeks ago and Panitta Partners didn’t sell a single share.
Key points from interview:
*Cherimon is permanent cure to dry eyes and big market for it.
* Funded to Develop Cherimon project, spend less money and bring Cherimon up to IND.
* Cherimon project will attract investors and VALUATION of OKYO WILL GO UP, which will attract funding down the road.
*Strong Pipeline 2019 and 2020
From the interview it’s clear, there won’t be any placing until cherimon delivered and Okyo value much higher, not my word, Directors word, listen to the interview and do your own research
But placing only when products potential are realised. Have you acually researched who is behind OKYO Mannnan? What else they are involved in and their successes? Placing at 20p to 40p range imho. 20 bagger
Brainer - it's market capitalisation not market capital
Mannnan doesn't tend to do research
Mannnan this is already heavily discounted from recent 8p highs and way oversold. 1.5p woukd be the lowest any placing would be at.
You must listen to this interview with Director, he is also the CEO of TILS (worth £133 millions in AIM and getting listed in NASDAQ soon. Go to this link: http://okyopharma.com
Key points:
*Cherimon is permanent cure to dry eyes and big market for it.
* Funded to Develop Cherimon project, spend less money and bring Cherimon up to IND.
* Cherimon project will attract investors and VALUATION of OKYO WILL GO UP, which will attract funding down the road.
*Strong Pipeline 2019 and 2020
From the interview it’s clear, there won’t be any placing until cherimon delivered and Okyo value much higher, not my word, Directors word, listen to the interview and do your own research
i think the placing at first at a discounted price .
https://www.medgadget.com/2018/10/dry-eye-syndrome-market-saw-a-dramatic-growth-of-cagr-6-6-usa-and-europe-top-the-list-forecast-2018-2023.html
That’s why Panitta Partners still hold all of their 47% holdings, they didn’t sell anything even when the share price went to 8p, they know the potential.
Panitta Partners is Major share holder of TILS, their market capital £133 millions
1s will be history soon into 2s soon imho
101 blue trade = 7am RNS
Mannnan = dodgy poster
Lovely little company on main market not AIM - filling my boots here. I now own lots of shares here. No brainer with the value of the 2 licenses they have and very little free float. Imho gla dyor. Anything sub 3p is a gifted price. 2p is a steal imho.